Side-by-side comparison of AI visibility scores, market position, and capabilities
Sarasota FL vertical software holding company (NASDAQ: ROP) at $7.04B 2024 revenue (+14%) and record $2.3B free cash flow; $3.6B acquisitions in 2024 (Procare Solutions, Transact Campus) competing with Constellation Software.
Roper Technologies, Inc. is a Sarasota, Florida-based diversified vertical software holding company — publicly traded on the NASDAQ (NASDAQ: ROP) as an S&P 500, NASDAQ 100, and Fortune 1000 component — acquiring and operating market-leading software and technology companies that serve niche vertical markets with high switching costs and recurring revenue models, generating $7.04 billion in revenue and a record $2.3 billion in free cash flow in fiscal year 2024. CEO Neil Hunn has led Roper's software transformation strategy, building a portfolio of 40+ vertical software businesses across three segments: Application Software (55% of 2024 revenue, including Aderant for legal management, Deltek for project-based businesses serving 23,000+ organizations, Vertafore for insurance distribution serving 20,000+ agencies, and Procare Solutions for early childhood education — acquired in 2024); Network Software (21%, including ConstructConnect, DAT Solutions freight marketplace, and iPipeline); and Technology Enabled Products (24%, including Verathon medical devices, Neptune water meter technology, and CIVCO Medical Solutions). In 2024, Roper deployed $3.6 billion on acquisitions including Procare Solutions and Transact Campus, maintaining $5+ billion in available M&A capital. Founded in 1890 as a home appliance and industrial manufacturer by George D. Roper, the company's strategic reinvention under former CEO Brian Jellison (early 2000s) into vertical software represents one of the most successful business model transformations in US industrial history.
Richmond VA tobacco and nicotine (NYSE: MO) ~$9.7B net revenue FY2024; Marlboro 40%+ US cigarette share, on! oral pouch competing with Zyn, 50%+ operating margins, ABI stake, competing with Reynolds/BAT.
Altria Group, Inc. is a Richmond, Virginia-based tobacco and nicotine company — publicly traded on the New York Stock Exchange (NYSE: MO) as an S&P 500 Consumer Staples component — manufacturing and selling cigarettes (Marlboro — the best-selling cigarette brand in the United States), smokeless tobacco (Copenhagen, Skoal, Red Seal, Husky chewing tobacco/moist snuff brands), oral nicotine pouches (on! brand), and maintaining a 10.7% ownership stake in Anheuser-Busch InBev (SABMiller acquisition consideration shares) and a 35% stake in JUUL Labs (vaping — original $12.8B investment written down to minimal value following JUUL's regulatory and litigation difficulties) through approximately 5,500 employees. In fiscal year 2024, Altria reported revenues of approximately $20.6 billion (net revenues after excise taxes approximately $9.7 billion), with the cigarette segment (Marlboro generating 40%+ US cigarette market share) contributing the majority of operating income at 50%+ adjusted operating margins — the highest margins in the consumer staples sector reflecting cigarettes' inelastic demand and regulated market structure. CEO Billy Gifford has pivoted Altria's strategy from cigarettes toward smoke-free nicotine products: the on! oral nicotine pouch (acquired full ownership of Helix Innovations in 2023, rebranding as on! to compete with Swedish Match Zyn, the dominant US oral nicotine pouch brand) represents Altria's primary nicotine product diversification vehicle as cigarette volume declines 7-8% annually through consumer quit rates and secular health awareness trends.
Monitor how your brand performs across ChatGPT, Gemini, Perplexity, Claude, and Grok daily.